Related Experiment Videos
Expression of neuronal markers during NTera2/cloneD1 differentiation by cell aggregation method
Francesca Megiorni1, Barbara Mora, Paola Indovina
1Department of Experimental Medicine and Pathology, La Sapienza University, Viale Regina Elena 324, 00161 Rome, Italy.
Neuroscience Letters
|November 30, 2004
Summary
Human teratocarcinoma cells treated with retinoic acid (RA) differentiate into neurons within 14 days. This study details the expression of key neural genes during this human neurogenesis process.
Area of Science:
- Neuroscience
- Developmental Biology
- Stem Cell Biology
Background:
- Human teratocarcinoma NTera2/cloneD1 (NT2) cells are a valuable in vitro model for studying human neurogenesis.
- Retinoic acid (RA) is known to induce neuronal differentiation in NT2 cells.
Purpose of the Study:
- To investigate the temporal expression patterns of neural genes during RA-induced neuronal differentiation of NT2 cells.
- To characterize the neuronal markers expressed during this differentiation process.
Main Methods:
- NT2 cells were aggregated and treated with retinoic acid (RA) for 14 days.
- Reverse transcription polymerase chain reaction (RT-PCR) was used to analyze mRNA expression of neural bHLH genes (Hes1, Ngn1, Mash1, NeuroD, Math1, Pax6) and neuronal markers (GluR, MAP2, Tau, NeuN).
- Western blotting was performed to confirm the expression of neuronal markers.
Main Results:
- NT2 cells expressed neural bHLH gene mRNAs (Hes1, Ngn1, Mash1, NeuroD, Math1, Pax6) early in RA exposure.
- Retinoic acid (RA) treatment modulated endogenous Ngn1 and Math1 transcripts.
- Expression of typical neuronal markers (GluR, MAP2, Tau, NeuN) was confirmed via RT-PCR and Western blotting.
Conclusions:
- RA treatment effectively induces neuronal differentiation in NT2 cells within 14 days.
- The study provides insights into the dynamic gene expression during human neuronal commitment.
- Understanding these molecular pathways can aid in investigating neurodevelopmental disorders.